Health-related quality of life in patients with multiple myeloma--does it matter?

Affiliations

¹ Department of Hematology, Akershus University Hospital, Lørenskog, Norwegian University of Science and Technology, Trondheim, Norway.
² Department of Hematology, Department of Medicine, St Olavs University Hopsital, and Jebsen Center for Myeloma Research, Institute of Cancer Research and Moleclar Medicine, Norwegian University of Science and Technology, Trondheim, Norway anders.waage@ntnu.no.

Editorial

Ann Kristin Kvam et al. Haematologica. 2015 Jun.

. 2015 Jun;100(6):704-5.

doi: 10.3324/haematol.2015.127860.

¹ Department of Hematology, Akershus University Hospital, Lørenskog, Norwegian University of Science and Technology, Trondheim, Norway.
² Department of Hematology, Department of Medicine, St Olavs University Hopsital, and Jebsen Center for Myeloma Research, Institute of Cancer Research and Moleclar Medicine, Norwegian University of Science and Technology, Trondheim, Norway anders.waage@ntnu.no.

No abstract available

Comment on

Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.
Delforge M, Minuk L, Eisenmann JC, Arnulf B, Canepa L, Fragasso A, Leyvraz S, Langer C, Ezaydi Y, Vogl DT, Giraldo-Castellano P, Yoon SS, Zarnitsky C, Escoffre-Barbe M, Lemieux B, Song K, Bahlis NJ, Guo S, Monzini MS, Ervin-Haynes A, Houck V, Facon T. Delforge M, et al. Haematologica. 2015 Jun;100(6):826-33. doi: 10.3324/haematol.2014.120121. Epub 2015 Mar 13. Haematologica. 2015. PMID: 25769541 Free PMC article. Clinical Trial.

1. Kristinsson SY, Anderson WF, Landgren O. Improved long-term survival in multiple myeloma up to the age of 80 years. Leukemia. 2014;28(6):1346–1348. - PubMed
1. Quality of life and clinical trials. Lancet. 1995;346(8966):1–2. - PubMed
1. U.S Department of Health and Human Services FDA. Guidance for Industry, Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009. - PMC - PubMed
1. Aaronson NK, Meyerowitz BE, Bard M, et al. Quality of life research in oncology. Past achievements and future priorities. Cancer. 1991;67(3 Suppl):839–843. - PubMed
1. Sprangers MA. Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol. 2002;41(3):229–237. - PubMed